ScoreHaematology
FLIPI and FLIPI-2 in follicular lymphoma
International prognostic indices for follicular lymphoma: FLIPI (overall survival) and FLIPI-2 (progression-free survival).
Updated 31 October 2026
When to use it
Patients with follicular lymphoma at diagnosis, to estimate prognosis and stratify trials; they do not decide alone when to treat.
What it needs
- Age > 60 years
- Haemoglobin < 12 g/dL
- Ann Arbor stage III–IV
- More than 4 nodal areas involved
- LDH above the upper limit of normal
- β2-microglobulin above the upper limit of normal
- Longest diameter of the largest node > 6 cm
- Bone marrow involvement
The points for each answer and the automatic total are in the app.
How to interpret it
| Result | Interpretation |
|---|---|
| ≤ 1 | Low risk (0–1 factors) |
| 2 | Intermediate risk (2 factors) |
| ≥ 3 | High risk (≥ 3 factors) |
In the app it also calculates: FLIPI-2.
Practical tip
The decision to treat rests on tumour burden and symptoms (e.g. GELF criteria), not on FLIPI.
2 more practical tips in the app.
Reference
- Solal-Céligny P, Roy P, Colombat P, et al. Follicular lymphoma international prognostic index. Blood. 2004;104(5):1258-1265.
- Federico M, Bellei M, Marcheselli L, et al. Follicular lymphoma international prognostic index 2: a new prognostic index for follicular lymphoma developed by the International Follicular Lymphoma Prognostic Factor Project. J Clin Oncol. 2009;27(27):4555-4562.
A support tool for healthcare professionals: it guides and does not replace clinical judgement.
